Table 2 Summary of FES-dbPET imaging results

From: Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol

Patient

SUVmax

SULmax

Tumor-normal ratio

FES uptake volume (cm3)

1

15.83 (V1)

9.32 (V1)

4.81 (V1)

15.72 (V1)

 

6.11 (V2)a

3.58 (V2)a

2.55(V2)a

0.37 (V2)a

2

22.42

15.65

4.3

35.63

3

13.02 (V1)

9.08 (V1)

8.04 (V1)

12.60 (V1)

 

16.26 (V2)b

11.61 (V2)b

8.74 (V2)b

6.97 (V2)b

4

7.44

5.67

2.52

0.22

5

No FES uptake detected due to the prior fertility preservation treatment with tamoxifen

6

No FES uptake detected

  1. aPatient FES-dbPET follow-up scan after 2 months of letrozole. V1 = baseline; V2 = follow-up
  2. bPatient FES-dbPET follow-up scan after 3 weeks of chemotherapy without endocrine treatment. V1 = baseline; V2 = follow-up
Back to article page